Drug Profile
U 91939
Alternative Names: U 91939ELatest Information Update: 28 May 2003
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class Antibacterials
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 16 Apr 2003 Pharmacia has been acquired by Pfizer
- 20 Apr 1995 No-Development-Reported for Bacterial infections in USA (Unknown route)